XK and viral infectious disease: This finding is supported by the report that vaccination with the recombinant NA protein of A/PR8 (H1N1) could provide complete homologous protection against A/PR8 (H1N1) virus infection but not heterosubtypic protection against H3N2 virus (Wohlbold et al., 2015).